SNOA icon

Sonoma Pharmaceuticals
SNOA

Overview Fund Activity

28 hedge funds and large institutions have $2.73M invested in Sonoma Pharmaceuticals in 2018 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 6 increasing their positions, 2 reducing their positions, and 1 closing their positions.

Holders
28
Holders Change
+6
Holders Change %
+27.27%
% of All Funds
0.64%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
6
Reduced
2
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
SM
1
Sabby Management
Florida
$255K
2
Vanguard Group
2
Vanguard Group
Pennsylvania
$373K
3
PAM
3
Panagora Asset Management
Massachusetts
$44K
4
RJA
4
Raymond James & Associates
Florida
$41K
5
PGA
5
Premia Global Advisors
Florida
$36K

Top Sellers

1
BA
1
Bard Associates
Illinois
$1.21M
2
Deutsche Bank
2
Deutsche Bank
Germany
$74K
3
Bank of Montreal
3
Bank of Montreal
Ontario, Canada
$0
Name Market Value Shares Shares
Change 		Shares
Change %
TRCT
26
Tower Research Capital (TRC)
New York
– – – –
Royal Bank of Canada
27
Royal Bank of Canada
Ontario, Canada
$0 7 – –
SEI Investments
28
SEI Investments
Pennsylvania
$0 4 – –
OIA
29
Optimum Investment Advisors
Illinois
$0 12 +12 New
ML
30
McAdam LLC
Pennsylvania
$0 71 +71 New
1
2